Company / Operating Income per Share
Marker Therapeutics, Inc. Operating Income per Share History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.78
FY2021
5-year range
-$1.08 / -$0.50
FY2018-FY2021
Trend
-56.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.08 to $-0.78 over the past 3 years.
Based on SEC 10-K filings.
-0.78 in FY2021.
Improved from $-1.08 to $-0.78 over the past 3 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating income per share decreased 56.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.78 | -56.9% |
| FY2019 | -$0.50 | +54.2% |
| FY2018 | -$1.08 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026